Chongqing Shenghuaxi Pharmaceutical Co.,Ltd. ( China (Mainland))

Chongqing Shenghuaxi Pharmaceutical Co.,Ltd., founded in September 1999 with registered capital of 25.08 million yuan, total assets of about 200 million yuan, is a high-tech enterprise in Chongqing City manufacturing bulk drugs and pharmaceutical preparations. The company has three factories, more than 10 workshops for production of full-sterile bulk drugs, non-sterile bulk drugs, three pharmaceutical preparations workshops, refined, bake, package workshops. The company also has seven synthetic drugs laboratories, two drug formulations and associated researches, the Science and Technology Analysis Center, an intelligence studio and a registered studio. The company established a good technical cooperation with many Pharmaceutical Universities, Pharmacy Research Institutes. Production lines for 11 kinds of bulk drugs and five kinds of agents passed the domestic GMP certification. Famciclovir (104227-87-4) and Ibandronate (114084-78-5) has been certified by the U.S. FDA. The preparation method of Famciclovir and the crystal of Duloxetine hydrochloride (136434-34-9) are world patents. Company has applied for 8 Chinese patents, of which two patents have been authorized.